SCLS |
Small Cell Lung Cancer |
NSCLC |
Non-Small Cell Lung Cancer |
EGFR |
Epidermal Growth Factor Receptor |
ALK |
Anaplastic Lymphoma Kinase |
TKI |
Tyrosine Kinase Inhibitor |
EML-4 |
Echinoderm Microtubule-associated Protein Like-4 |
FDA |
Food and Drug Administration |
PFS |
Progression-Free Survival |
CT |
Computed Tomography |
MRI |
Magnetic Resonance Imaging |
CK7+ |
Cytokeratine 7+ |
TTF1+ |
Transcriptional Thyroid Factor 1+ |
ROS1 |
c-Ros Oncogene 1 |
CTCAE |
Common Terminology Criteria for Adverse Events |
CNS |
Central Nervous System |
BBB |
Blood-Brain Barrier |